Pharma
Back to News_

Inotec AMD double in size at Cambridge Research Park

The oxygen wound therapy developer, NATROX® (registered trade mark of Inotec AMD Limited) has taken another floor at Cambridge Research Park, taking their total footprint to 5,600 sq. ft. Inotec first established themselves at the growing R&D hub in 2017, which offers a range of office, R&D, plug&play suites, lab and high-tech accommodation.

XLB Property asset manage Cambridge Research Park on behalf of Royal London Asset Management, a business community set in acres of landscaped grounds and part of the Cambridge Compass Local Enterprise Zone. Thanks to our appointed leasing agents Rupert Dando Savills, Bidwells, and Cheffins.